5-Bromo-4-methyl-N-((tetrahydro-2H-pyran-4-yl)methyl)pyridin-2-amine

Catalog No. :
ACEOSC832
CAS No. :
1220029-53-7
Molecular Formula :
C12H17BrN2O
Molecular Weight :
285.18

IUPAC Name:5-bromo-4-methyl-N-((tetrahydro-2H-pyran-4-yl)methyl)pyridin-2-amine

5-Bromo-4-methyl-N-((tetrahydro-2H-pyran-4-yl)methyl)pyridin-2-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$142.00Login to see priceInquiryInquiry
5g95%$427.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Bromo-4-methyl-N-((tetrahydro-2H-pyran-4-yl)methyl)pyridin-2-amine
IUPAC Name5-bromo-4-methyl-N-((tetrahydro-2H-pyran-4-yl)methyl)pyridin-2-amine
MDL No.MFCD13562853
Molecular FormulaC12H17BrN2O
Molecular Weight285.18
SMILESCC1=CC(NCC2CCOCC2)=NC=C1Br
InChI KeyOBOBPOLWLSMAJP-UHFFFAOYSA-N
Synonym5-Bromo-4-methyl-N-(tetrahydro-2H-pyran-4-ylmethyl)-2-pyridinamine;5-BROMO-4-METHYL-N-((TETRAHYDRO-2H-PYRAN-4-YL)METHYL)PYRIDIN-2-AMINE;2-Pyridinamine, 5-bromo-4-methyl-N-[(tetrahydro-2H-pyran-4-yl)methyl]-
CAS No.1220029-53-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACEOSC832 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNJZW985 route compound structure diagram
    ACNJZW98598198-48-2 In Stock
  2. Plus
  3. ACGLQZ506 route compound structure diagram
    ACGLQZ50650675-18-8 In Stock
  4. Then
  5. ACEOSC832 route product structure diagram
    ACEOSC8321220029-53-7
Inquiry

2. ACEOSC832 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACEOSC832 route product structure diagram
    ACEOSC8321220029-53-7
Inquiry

Comments (0)